Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-114491
Filing Date
2024-11-06
Accepted
2024-11-06 06:12:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2427472d2_defa14a.htm DEFA14A 251090
  Complete submission text file 0001104659-24-114491.txt   252233
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40323 | Film No.: 241429111
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)